"Licensing fees from this product will go straight to the company's bottom line and will give patients a high dosage capsule at an affordable price."

I'm really looking forward to Q1 and the bottom line. Let's hope this trend reverses course soon, and the launch of PharmaJanes means we've started collecting cash.